VALENCIA, 13 ( EUROPA PRESS)
the doctor Jose Mir has joined as surgeon Emeritus, consultant and researcher to the Hospital in Manises (Valencia), which will work with the hospital General Surgery service in the development of the area which deals with diseases of pancreas and liver, as reported by the hospital said in a statement.
As explained, his work will be designed to contribute its expertise in the surgical field, especially in the area of hepatobiliopancreática, especially in the case of extreme surgery surgery.
His career in this field “will allow to provide great added value in the implementation underway of new services and techniques in the three most important in their specialty areas of complicated biliary tract surgery, pancreatic surgery, and surgery liver, either by primitive tumors or metastases”, has indicated the specialist.
El doctor Mir was the first Valencian surgeon that performed liver transplantation in the Comunitat. It has extensive international training centres as New Addenbrookes in Cambridge, the Cantonal Hospital of Lausanne in Switzerland, the unity of Trasplante Hepático at the University of California, the U.C.S.F. Hospital of San Francisco or unity of Trasplante Hepático in Kyoto University. In 2002 he also began training and accreditation for transplant of pancreas in Minneapolis.
The new Emeritus surgeon of the Hospital of Manises has developed most of his career in the Hospital Universitario La Fe, where he held various positions of relevance. He was head of surgery and unit Trasplante Hepático of the Center, Chief of service of General Surgery and digestive and finally since 2003, director of the surgical area.
Under its coordination Hospital La Fe has consolidated as a reference centre for the treatment of liver disease, pancreatic and liver transplantation. Thus, he has made nearly 1,800 interventions representing 10 per cent of all national transplants, 5 per cent in Europe and 1 percent of worldwide experience.
Also its research aspect is particularly relevant. Dr. Mir contributed to the launch of the programme of hepatic cell therapy, based on isolation, cultivation and transplant of human hepatocytes from bodies discarded for transplantation, such as alternativa-complemento to liver transplantation of solid organ and the congenital metabulopatÃas. It also highlights their contribution in the field of liver regenerative medicine. Indeed Prize Jaime I 2010 clinical research.
